Latest Insider Transactions at Blueprint Medicines Corp (BPMC)
This section provides a real-time view of insider transactions for Blueprint Medicines Corp (BPMC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Blueprint Medicines Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Blueprint Medicines Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 02
2024
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,834
+9.87%
|
$99,036
$54.13 P/Share
|
|
Mar 28
2024
|
Michael Landsittel CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,000
-9.56%
|
$475,000
$95.0 P/Share
|
|
Mar 28
2024
|
Michael Landsittel CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+8.73%
|
$180,000
$36.05 P/Share
|
|
Mar 20
2024
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
25,073
-2.62%
|
$2,181,351
$87.33 P/Share
|
|
Mar 20
2024
|
Jeffrey W. Albers |
BUY
Exercise of conversion of derivative security
|
Direct |
25,073
+6.02%
|
$200,584
$8.44 P/Share
|
|
Mar 15
2024
|
Michael Landsittel CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
13,734
-4.14%
|
$1,208,592
$88.06 P/Share
|
|
Mar 15
2024
|
Michael Landsittel CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+7.57%
|
$180,000
$36.05 P/Share
|
|
Mar 15
2024
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
4,549
-8.36%
|
$400,312
$88.19 P/Share
|
|
Mar 15
2024
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,600
+4.11%
|
$24,000
$15.01 P/Share
|
|
Mar 13
2024
|
Philina Lee CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
8,023
-9.74%
|
$722,070
$90.22 P/Share
|
|
Mar 13
2024
|
Philina Lee CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,747
+2.01%
|
$19,217
$11.91 P/Share
|
|
Mar 07
2024
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
11,033
-6.27%
|
$992,970
$90.69 P/Share
|
|
Mar 07
2024
|
Philina Lee CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,934
-6.68%
|
$264,060
$90.69 P/Share
|
|
Mar 07
2024
|
Kate Haviland CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
12,464
-7.52%
|
$1,121,760
$90.69 P/Share
|
|
Mar 07
2024
|
Debra Durso Bumpus CHIEF PEOPLE OFFICER |
SELL
Open market or private sale
|
Direct |
5,093
-8.13%
|
$458,370
$90.69 P/Share
|
|
Mar 07
2024
|
L. Becker Hewes CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,097
-6.27%
|
$278,730
$90.69 P/Share
|
|
Mar 07
2024
|
Fouad Namouni PRESIDENT, R & D |
SELL
Open market or private sale
|
Direct |
4,377
-5.68%
|
$393,930
$90.69 P/Share
|
|
Mar 07
2024
|
Christina Rossi CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
6,070
-8.63%
|
$546,300
$90.69 P/Share
|
|
Mar 07
2024
|
Michael Landsittel CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,003
-8.2%
|
$450,270
$90.69 P/Share
|
|
Mar 07
2024
|
Christopher K. Murray CHIEF TECHNICAL OPERATIONS |
SELL
Open market or private sale
|
Direct |
2,521
-6.93%
|
$226,890
$90.69 P/Share
|
|
Mar 07
2024
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
1,462
-7.57%
|
$131,580
$90.69 P/Share
|
|
Mar 07
2024
|
Tracey L Mc Cain EVP AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,194
-7.91%
|
$467,460
$90.69 P/Share
|
|
Mar 07
2024
|
Percy H. Carter CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,286
-4.52%
|
$205,740
$90.69 P/Share
|
|
Mar 04
2024
|
Christopher K. Murray CHIEF TECHNICAL OPERATIONS |
SELL
Open market or private sale
|
Direct |
621
-1.68%
|
$57,753
$93.65 P/Share
|
|
Mar 01
2024
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+20.56%
|
-
|
|
Mar 01
2024
|
Tracey L Mc Cain EVP AND CHIEF LEGAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+15.99%
|
-
|
|
Mar 01
2024
|
Philina Lee CHIEF COMMERCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+22.15%
|
-
|
|
Mar 01
2024
|
Christina Rossi CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+17.57%
|
-
|
|
Mar 01
2024
|
Debra Durso Bumpus CHIEF PEOPLE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+16.63%
|
-
|
|
Mar 01
2024
|
Fouad Namouni PRESIDENT, R & D |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+16.29%
|
-
|
|
Mar 01
2024
|
Percy H. Carter CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+19.8%
|
-
|
|
Mar 01
2024
|
Michael Landsittel CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+17.0%
|
-
|
|
Mar 01
2024
|
Kate Haviland CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+19.45%
|
-
|
|
Mar 01
2024
|
L. Becker Hewes CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+20.2%
|
-
|
|
Mar 01
2024
|
Christopher K. Murray CHIEF TECHNICAL OPERATIONS |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+25.26%
|
-
|
|
Feb 28
2024
|
Christopher K. Murray CHIEF TECHNICAL OPERATIONS |
SELL
Open market or private sale
|
Direct |
5,000
-16.95%
|
$500,000
$100.0 P/Share
|
|
Feb 28
2024
|
Christopher K. Murray CHIEF TECHNICAL OPERATIONS |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+14.49%
|
$270,000
$54.13 P/Share
|
|
Jan 25
2024
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
25,000
-3.24%
|
$2,050,000
$82.3 P/Share
|
|
Jan 25
2024
|
Jeffrey W. Albers |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+6.01%
|
$200,000
$8.44 P/Share
|
|
Dec 22
2023
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
714
-4.75%
|
$64,260
$90.0 P/Share
|
|
Dec 22
2023
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
714
+4.53%
|
$5,712
$8.8 P/Share
|
|
Dec 15
2023
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
3,914
-8.02%
|
$328,776
$84.35 P/Share
|
|
Dec 15
2023
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,654
+10.02%
|
$3,654
$1.87 P/Share
|
|
Dec 13
2023
|
Philina Lee CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
261
+0.82%
|
$261
$1.87 P/Share
|
|
Dec 11
2023
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
5,000
-2.76%
|
$395,000
$79.07 P/Share
|
|
Dec 11
2023
|
Jeffrey W. Albers |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+2.69%
|
$180,000
$36.05 P/Share
|
|
Dec 07
2023
|
Christopher K. Murray CHIEF TECHNICAL OPERATIONS |
SELL
Open market or private sale
|
Direct |
5,000
-16.95%
|
$375,000
$75.0 P/Share
|
|
Dec 07
2023
|
Christopher K. Murray CHIEF TECHNICAL OPERATIONS |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+14.49%
|
$270,000
$54.13 P/Share
|
|
Dec 04
2023
|
Christopher K. Murray CHIEF TECHNICAL OPERATIONS |
SELL
Open market or private sale
|
Direct |
600
-2.39%
|
$42,600
$71.43 P/Share
|
|
Nov 30
2023
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
5,000
-2.76%
|
$350,000
$70.55 P/Share
|